Jump to ContentJump to Main Navigation

You are looking at 1-20 of 84 items

  • Keywords: pharmaceutical industries x
Clear All Modify Search

View:

Patterns and Practices in Three Process Industries: Petroleum, Chemical, and Pharmaceuticals

James W. Cortada

in The Digital Hand, Vol 1: How Computers Changed the Work of American Manufacturing, Transportation, and Retail Industries

Published in print:
2004
Published Online:
September 2007
ISBN:
9780195165883
eISBN:
9780199789672
Item type:
chapter
Publisher:
Oxford University Press
DOI:
10.1093/acprof:oso/9780195165883.003.0006
Subject:
Business and Management, Business History

This chapter describes how computers came into the petroleum, chemical, and pharmaceutical process and manufacturing industries. It argues that computers fundamentally changed the nature of work in ... More


Global value chains in the pharmaceutical industry

Jocelyn Probert

in Recovering from Success: Innovation and Technology Management in Japan

Published in print:
2006
Published Online:
September 2007
ISBN:
9780199297320
eISBN:
9780191711237
Item type:
chapter
Publisher:
Oxford University Press
DOI:
10.1093/acprof:oso/9780199297320.003.0005
Subject:
Business and Management, Innovation

This chapter looks at value chains in the Japanese pharmaceutical industry, which was, until recently, relatively isolated from global consolidation, value chain modularization, and indeed global ... More


One Political Economy, One Competitive Strategy?: Comparing Pharmaceutical Firms in Germany, Italy, and the UK

Andrea M. Herrmann

Published in print:
2008
Published Online:
January 2009
ISBN:
9780199543434
eISBN:
9780191715693
Item type:
book
Publisher:
Oxford University Press
DOI:
10.1093/acprof:oso/9780199543434.001.0001
Subject:
Business and Management, Strategy, Political Economy

This book examines how firms adapt to the pressures of increasing international competition by testing both the arguments on ‘strategy specialization’ proposed in the competitiveness literature in ... More


Crafting the Medicare Modernization Act of 2003

Kimberly J. Morgan and Andrea Louise Campbell

in The Delegated Welfare State: Medicare, Markets, and the Governance of Social Policy

Published in print:
2011
Published Online:
January 2012
ISBN:
9780199730346
eISBN:
9780199918447
Item type:
chapter
Publisher:
Oxford University Press
DOI:
10.1093/acprof:oso/9780199730346.003.0005
Subject:
Political Science, American Politics

Chapter five examines the passage of the Medicare Modernization Act of 2003—a major social policy reform that delegates responsibility for a Medicare prescription drug benefit to commercial firms. ... More


How the Government Created the Pharmaceutical Industry

Robert I. Field

in Mother of Invention: How the Government Created "Free-Market" Health Care

Published in print:
2013
Published Online:
January 2014
ISBN:
9780199746750
eISBN:
9780199354528
Item type:
chapter
Publisher:
Oxford University Press
DOI:
10.1093/acprof:oso/9780199746750.003.0003
Subject:
Public Health and Epidemiology, Public Health

The pharmaceutical industry, perennially one of the most profitable,requires a steady flow of biomedical research to develop new products. However, investment in basic scienceis difficult for private ... More


Natural Products and the Pharmaceutical Industry

Richard Firn

in Nature's Chemicals: The Natural Products that shaped our world

Published in print:
2009
Published Online:
February 2010
ISBN:
9780199566839
eISBN:
9780191721700
Item type:
chapter
Publisher:
Oxford University Press
DOI:
10.1093/acprof:oso/9780199566839.003.0007
Subject:
Biology, Ecology, Biochemistry / Molecular Biology

Natural Products have been exploited by humans as a means of treating illness, ailments and infections throughout recorded human history. Worldwide, NPs are still of major importance in health care. ... More


The legal market: prescription and diversion of psychopharmaceuticals

Thomas Babor, Jonathan Caulkins, Griffith Edwards, Benedikt Fischer, David Foxcroft, Keith Humphreys, Isidore Obot, Jürgen Rehm, Peter Reuter, Robin Room, Ingeborg Rossow, and John Strang

in Drug Policy and the Public Good

Published in print:
2009
Published Online:
May 2010
ISBN:
9780199557127
eISBN:
9780191721373
Item type:
chapter
Publisher:
Oxford University Press
DOI:
10.1093/acprof:oso/9780199557127.003.006
Subject:
Public Health and Epidemiology, Public Health, Epidemiology

Chapter 5 described what is known about the structure, prices, and products of illegal drug markets, and the nature and extent of harms that arise from them. This chapter describes another drug ... More


Pharmaceuticals and the health sector

Prashant Yadav, Richard D. Smith, and Kara Hanson

in Health Systems in Low- and Middle-Income Countries: An economic and policy perspective

Published in print:
2011
Published Online:
January 2012
ISBN:
9780199566761
eISBN:
9780191731181
Item type:
chapter
Publisher:
Oxford University Press
DOI:
10.1093/acprof:oso/9780199566761.003.0061
Subject:
Public Health and Epidemiology, Public Health, Epidemiology

This chapter consolidates existing knowledge around the role, structure, and improvement levers of pharmaceutical systems, and reviews issues facing the pharmaceutical component of health sectors in ... More


Pharmaceuticals

Hiroyuki Odagiri and Akira Goto

in Technology and Industrial Development in Japan: Building Capabilities by Learning, Innovation and Public Policy

Published in print:
1996
Published Online:
October 2011
ISBN:
9780198288022
eISBN:
9780191684555
Item type:
chapter
Publisher:
Oxford University Press
DOI:
10.1093/acprof:oso/9780198288022.003.0011
Subject:
Economics and Finance, South and East Asia

This chapter discusses the history of the pharmaceutical industry in Japan, detailing the rise and fall of pharmaceutical firms. The history of the pharmaceutical industry is separated into five ... More


12. 12. Broadening the Marketing Concept: Service to Humanity, or Privatization of the Public Good?

Kalman Applbaum

in Inside Marketing: Practices, Ideologies, Devices

Published in print:
2011
Published Online:
May 2011
ISBN:
9780199576746
eISBN:
9780191724916
Item type:
chapter
Publisher:
Oxford University Press
DOI:
10.1093/acprof:oso/9780199576746.003.0013
Subject:
Business and Management, Marketing

Is humanistic marketing possible? Can the marketing concept be suitably applied beyond commercial situations and to the public interest? Is marketing a universal tool, a technology, even a science ... More


From Molecules to Medicines: The Use of Genetic Resources in Pharmaceutical Research

Astrid J. Scholz

in Engineering Trouble: Biotechnology and Its Discontents

Published in print:
2003
Published Online:
March 2012
ISBN:
9780520237612
eISBN:
9780520937499
Item type:
chapter
Publisher:
University of California Press
DOI:
10.1525/california/9780520237612.003.0009
Subject:
History, History of Science, Technology, and Medicine

This chapter describes the drug discovery process in pharmaceutical research to show how deeply the new biotechnologies constitute the politics and economics of genetic resources. The analysis ... More


Measuring Competence? Exploring Firm Effects in Drug Discovery

Rebecca Henderson and Iain Cockburn

in The Nature and Dynamics of Organizational Capabilities

Published in print:
2001
Published Online:
November 2003
ISBN:
9780199248544
eISBN:
9780191596155
Item type:
chapter
Publisher:
Oxford University Press
DOI:
10.1093/0199248540.003.0007
Subject:
Economics and Finance, Microeconomics

The chapter explores the role of ‘competence’ in pharmaceutical research. It provides support for the existence of sources of heterogeneity highlighted by the resource‐based view of the firm by ... More


Pharmaceutical Geographies: Mapping the Boundaries of the Therapeutic Revolution

Jeremy A. Greene

in Therapeutic Revolutions: Pharmaceuticals and Social Change in the Twentieth Century

Published in print:
2016
Published Online:
May 2017
ISBN:
9780226390734
eISBN:
9780226390901
Item type:
chapter
Publisher:
University of Chicago Press
DOI:
10.7208/chicago/9780226390901.003.0007
Subject:
History, History of Science, Technology, and Medicine

This chapter traces how a new critique of differential access to therapeutics developed in American domestic health policy and approaches to international development over the course of the 1960s and ... More


Unsettling Drug Patent Settlements: A Framework for Presumptive Illegality

Michael A. Carrier

in Innovation for the 21st Century: Harnessing the Power of Intellectual Property and Antitrust Law

Published in print:
2009
Published Online:
May 2009
ISBN:
9780195342581
eISBN:
9780199867035
Item type:
chapter
Publisher:
Oxford University Press
DOI:
10.1093/acprof:oso/9780195342581.003.0015
Subject:
Law, Intellectual Property, IT, and Media Law

This chapter explains why agreements by which brand-name pharmaceutical companies pay generic firms to settle patent infringement litigation and agree to delay entering the market should be ... More


Morals and Medicines

David M. Webber

in Global Statesman: How Gordon Brown Took New Labour to the World

Published in print:
2017
Published Online:
May 2018
ISBN:
9781474423564
eISBN:
9781474438384
Item type:
chapter
Publisher:
Edinburgh University Press
DOI:
10.3366/edinburgh/9781474423564.003.0006
Subject:
Political Science, UK Politics

The second case study, explored here in chapter 6, addresses the commitment of the New Labour government to increase the availability of antiretroviral (ARV) drugs needed to combat HIV and AIDS in ... More


Three Views of a Train Wreck

Michael Kinch

in Prescription for Change: The Looming Crisis in Drug Development

Published in print:
2016
Published Online:
May 2017
ISBN:
9781469630625
eISBN:
9781469630649
Item type:
chapter
Publisher:
University of North Carolina Press
DOI:
10.5149/northcarolina/9781469630625.003.0012
Subject:
Business and Management, Innovation

Despite and arguably because of the enormous public health benefits arising from the introduction of new medicines, the industry is in the midst of crisis. We detail in this chapter the decline in ... More


Sources of Competitiveness of Large Mexican Groups

Robert Grosse and Douglas Thomas

in Can Latin American Firms Compete?

Published in print:
2007
Published Online:
January 2008
ISBN:
9780199233755
eISBN:
9780191715549
Item type:
chapter
Publisher:
Oxford University Press
DOI:
10.1093/acprof:oso/9780199233755.003.0011
Subject:
Business and Management, International Business

This chapter examines the processes of organizational adaptation and competitiveness of firms in an emerging economy. The study is set in the Argentine context of the 1990s when a combination of ... More


Volatility, Speculation, and Therapeutic Revolutions in Nigerian Drug Markets

Kristin Peterson

in Therapeutic Revolutions: Pharmaceuticals and Social Change in the Twentieth Century

Published in print:
2016
Published Online:
May 2017
ISBN:
9780226390734
eISBN:
9780226390901
Item type:
chapter
Publisher:
University of Chicago Press
DOI:
10.7208/chicago/9780226390901.003.0010
Subject:
History, History of Science, Technology, and Medicine

At the close of the 1970s, Nigeria was home to a thriving brand-name pharmaceutical market for which very few generic products even existed. The convergence of structural adjustment in Africa and the ... More


What’s Good for Us is Good for You: The Transnational Pharmaceutical Sector and Mexico’s Internationalist Patent System

Kenneth C. Shadlen

in Coalitions and Compliance: The Political Economy of Pharmaceutical Patents in Latin America

Published in print:
2017
Published Online:
August 2017
ISBN:
9780199593903
eISBN:
9780191845574
Item type:
chapter
Publisher:
Oxford University Press
DOI:
10.1093/oso/9780199593903.003.0007
Subject:
Political Science, Political Economy

This chapter analyses the political economy of continuity in Mexico. High levels of patenting and accentuated transnational dominance of the pharmaceutical industry, both functions of the choices of ... More


Fraud in the Pharmaceutical, Medical Equipment, and Supply Industries: Profits at Any Cost, Part Two

Terry L. Leap

in Phantom Billing, Fake Prescriptions, and the High Cost of Medicine: Health Care Fraud and What to Do about It

Published in print:
2011
Published Online:
August 2016
ISBN:
9780801449796
eISBN:
9780801460807
Item type:
chapter
Publisher:
Cornell University Press
DOI:
10.7591/cornell/9780801449796.003.0005
Subject:
Sociology, Health, Illness, and Medicine

This chapter examines frauds instigated by pharmaceutical companies as well as the medical supply and equipment industry. It first considers how large-scale frauds occur in the pricing, marketing, ... More


View: